Patents by Inventor Donna C. Porter

Donna C. Porter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
    Publication number: 20020051768
    Abstract: The present invention pertains to a method of er capsidating a recombinant poliovirus nucleic acid to obtain a yield of encapsidated viruses which substantially comprises encapsidated recombinant poliovirus nucleic acid. The method of encapsidating a recombinant poliovirus nucleic acid includes contacting a host cell with a recombinant poliovirus nucleic acid which lacks the nucleotide sequence encoding at least a portion of a protein necessary for encapsidation and an expression vector comprising a nucleic acid which encodes at least a portion of one protein necessary for encapsidation under conditions appropriate for introduction of the recombinant poliovirus nucleic acid and the expression vector into the host cell and obtaining a yield of encapsidated viruses which substantially comprises an encapsidated recombinant poliovirus nucleic acid.
    Type: Application
    Filed: January 8, 2001
    Publication date: May 2, 2002
    Inventors: Casey D. Morrow, Donna C. Porter, David C. Ansardi
  • Encapsidated recombinant viral nucleic acid and methods of making and using same
    Patent number: 6063384
    Abstract: The present invention pertains to a method of encapsidating a recombinant poliovirus nucleic acid to obtain a yield of encapsidated viruses which substantially comprises encapsidated recombinant poliovirus nucleic acid. The method of encapsidating a recombinant poliovirus nucleic acid includes contacting a host cell with a recombinant poliovirus nucleic acid which lacks the nucleotide sequence encoding at least a portion of a protein necessary for encapsidation and an expression vector comprising a nucleic acid which encodes at least a portion of one protein necessary for encapsidation under conditions appropriate for introduction of the recombinant poliovirus nucleic acid and the expression vector into the host cell and obtaining a yield of encapsidated viruses which substantially comprises an encapsidated recombinant poliovirus nucleic acid.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: May 16, 2000
    Assignee: The UAB Research Foundation
    Inventors: Casey D. Morrow, Donna C. Porter, David C. Ansardi
  • Encapsidated recombinant viral nucleic acid and methods of making and using same
    Patent number: 5817512
    Abstract: The present invention pertains to a method of encapsidating a recombinant poliovirus nucleic acid to obtain a yield of encapsidated viruses which substantially comprises encapsidated recombinant poliovirus nucleic acid. The method of encapsidating a recombinant poliovirus nucleic acid includes contacting a host cell with a recombinant poliovirus nucleic acid which lacks the nucleotide sequence encoding at least a portion of a protein necessary for encapsidation and an expression vector comprising a nucleic acid which encodes at least a portion of one protein necessary for encapsidation under conditions appropriate for introduction of the recombinant poliovirus nucleic acid and the expression vector into the host cell and obtaining a yield of encapsidated viruses which substantially comprises an encapsidated recombinant poliovirus nucleic acid.
    Type: Grant
    Filed: February 15, 1995
    Date of Patent: October 6, 1998
    Assignee: The UAB Research Foundation
    Inventors: Casey D. Morrow, Donna C. Porter, David C. Ansardi